# Treatment of Moderate to Severe Glabellar Lines (BMI2006)

> **NCT05531968** · PHASE3 · COMPLETED · sponsor: **BMI Korea** · enrollment: 278 (actual)

## Conditions studied

- Glabellar Lines

## Interventions

- **BIOLOGICAL:** BMI2006
- **BIOLOGICAL:** BOTOX®

## Key facts

- **NCT ID:** NCT05531968
- **Lead sponsor:** BMI Korea
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-09
- **Primary completion:** 2021-08-10
- **Final completion:** 2021-09-17
- **Target enrollment:** 278 (ACTUAL)
- **Last updated:** 2022-09-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05531968

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05531968, "Treatment of Moderate to Severe Glabellar Lines (BMI2006)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05531968. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*